Drug intelligence / Profile preview

OVU Plus

Development stage
Unknown
Lead developer
MEDcell
Modality
Small Molecules
Administration
Oral
01

Overview

OVU Plus is a fixed-dose combination nutraceutical product developed by Medcell Pharma for the management of polycystic ovary syndrome (PCOS) and associated female infertility. It is formulated as chewable tablets containing myo-inositol, D-chiro-inositol, vitamin D3 (cholecalciferol), L-methylfolate (levomefolic acid), and berberine. The combination of myo-inositol and D-chiro-inositol in a specific ratio is designed to improve insulin sensitivity, restore ovulatory function, and reduce hyperandrogenism. Berberine further supports metabolic health and insulin sensitivity, while vitamin D3 and L-methylfolate address nutritional deficiencies and support overall reproductive health and oocyte quality.

Brand names
OVU Plus
Other names
Myo-Inositol + D-chiro Inositol + Vitamin D3 + L-Methyl Folate + BerberineOVU PLUS
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on OVU Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OVU Plus.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call